Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 83, Issue 20, 1986, Pages 7785-7789

  Hamada, H ^a   Tsuruo, T ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DACTINOMYCIN H 3; DOXORUBICIN; DOXORUBICIN C 14; GLYCOPROTEIN; MONOCLONAL ANTIBODY; RADIOISOTOPE; UNCLASSIFIED DRUG; VINCRISTINE; VINCRISTINE H 3;

ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CELL LINE; DRUG RESISTANCE; DRUG TRANSPORT; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHARMACOKINETICS; PRIORITY JOURNAL; THERAPY; TUMOR CELL;

ANIMALIA;

EID: 0345139075     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.83.20.7785     Document Type: Article

References (0)